Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PK/PD”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03579030
What this trial is testing

Safety and PK/PD of RTA 1701 in Healthy Adults

Who this might be right for
Healthy
Biogen 90
Early research (Phase 1)Study completedNCT03870100
What this trial is testing

The PK/PD Study of A Single Subcutaneous Injection of SHR-1222 in Healthy Subjects

Who this might be right for
Osteoporosis
Jiangsu HengRui Medicine Co., Ltd. 50
Early research (Phase 1)Study completedNCT00990067
What this trial is testing

Interaction Between Duloxetine and 3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy)

Who this might be right for
Mood DisorderSubstance-Related DisordersAmphetamine-Related Disorders
University Hospital, Basel, Switzerland 16
Early research (Phase 1)Looking for participantsNCT05522868
What this trial is testing

SB17170 Phase 1 Clinical Trial in Solid Tumors

Who this might be right for
Solid Tumor
SPARK Biopharma 50
Testing effectiveness (Phase 2)Study completedNCT06750276
What this trial is testing

Evaluate the Safety, Tolerability, PK, and PD Effects of AZD2389 in Participants With Liver Fibrosis and Compensated Cirrhosis.

Who this might be right for
Liver FibrosisHepatic Cirrhosis
AstraZeneca 40
Testing effectiveness (Phase 2)Study completedNCT05284617
What this trial is testing

Exploratory Ph 2A, Double-Blind, Placebo-Controlled Dose Escalation Study of Safety, Tolerability, PD, & PK of HU6 for Subjects With Obese HFpEF

Who this might be right for
Heart Failure With Preserved Ejection Fraction
Rivus Pharmaceuticals, Inc. 67
Early research (Phase 1)Study completedNCT02329561
What this trial is testing

PK PD of the Enantiomers of Tramadol and O-desmethyltramadol in Elderly and Young Subjects

Who this might be right for
AgingPain
Université de Montréal 35
Early research (Phase 1)Looking for participantsNCT07462780
What this trial is testing

A Phase I Clinical Trial to Evaluate CMS-D017 Following Single and Multiple Doses in Healthy Participants

Who this might be right for
Paroxysmal Nocturnal Hemoglobinuria, PNHComplement-mediated Kidney Disease
Shenzhen Kangzhe Biotechnology Co., Ltd. 88
Early research (Phase 1)Study completedNCT03781947
What this trial is testing

Parenterally-administered Teverelix TFA in Healthy Male Volunteers

Who this might be right for
Healthy
Antev Ltd. 48
Early research (Phase 1)Study completedNCT00905138
What this trial is testing

First-in-Human Single Ascending and Multiple Dose of GLPG0259

Who this might be right for
Healthy
Lakefront Biotherapeutics NV 32
Testing effectiveness (Phase 2)Study completedNCT01498185
What this trial is testing

BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes

Who this might be right for
Type 1 Diabetes Mellitus
AstraZeneca 171
Large-scale testing (Phase 3)Study completedNCT00600808
What this trial is testing

Sustained Release Formulation of Somatropin (rDNA Origin)for Injection

Who this might be right for
Growth Hormone Deficiency
BioPartners GmbH 51
Testing effectiveness (Phase 2)Looking for participantsNCT07161258
What this trial is testing

A Pharmacokinetics (PK), Pharmacodynamics (PD), Safety and Tolerability Study of Fenebrutinib in Children and Adolescents With Relapsing Multiple Sclerosis (RMS)

Who this might be right for
Relapsing Multiple Sclerosis
Hoffmann-La Roche 12
Early research (Phase 1)Study completedNCT05594043
What this trial is testing

MK-6598 as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Advanced Solid Tumors (MK-6598-001)

Who this might be right for
Advanced or Metastatic Solid Tumors
Merck Sharp & Dohme LLC 39
Not applicableUnknownNCT03306550
What this trial is testing

Mechanism of Drug-drug Interaction Between Salvianolate Injection and Aspirin

Who this might be right for
Angina, Stable
Xiyuan Hospital of China Academy of Chinese Medical Sciences 18
Large-scale testing (Phase 3)Active Not RecruitingNCT05196035
What this trial is testing

Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Children With Chronic Kidney Disease and Proteinuria

Who this might be right for
Chronic Kidney DiseaseProteinuria
Bayer 219
Post-approval studies (Phase 4)Study completedNCT04634162
What this trial is testing

PD and PK Profiles of Switching Between Cangrelor and Ticagrelor Following Ticagrelor Pre-treatment

Who this might be right for
Coronary Artery Disease
University of Florida 22
Testing effectiveness (Phase 2)Ended earlyNCT01033019
What this trial is testing

To Evaluate the Safety, Local Tolerability, PK and PD of LDE225 on Sporadic Superficial and Nodular Skin Basal Cell Carcinomas (sBCC)

Who this might be right for
Sporadic Superficial and Nodular Skin Basal Cell Carcinomas
Novartis Pharmaceuticals 25
Early research (Phase 1)Study completedNCT03693950
What this trial is testing

The Study of PK, PD, Safety of Multiple Intravenous Injections of BCD-066 and Aranesp in Healthy Volunteers

Who this might be right for
Healthy
Biocad 57
Post-approval studies (Phase 4)Study completedNCT02365272
What this trial is testing

Pharmacokinetic/Pharmacodynamic Evaluation Amikacin in Critically Ill Patients Admitted at the Emergency Department

Who this might be right for
Sepsis
Universitaire Ziekenhuizen KU Leuven 100
Next Page